Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00701_DB00909_nanopub.RAv2bd9QgB2jtBROFwOxU1pfQBwIVPOxfytYKySimihPQ#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00701_DB00909 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00701_DB00909 label "DDI between Amprenavir and Zonisamide - Amprenavir, a strong CYP3A4 inhibitor, may increase the serum concentration of zonisamide by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zonisamide if amprenavir is initiated, discontinued or dose changed. [drugbank_resource:DB00701_DB00909]" assertion.
- drugbank_resource:DB00701_DB00909 identifier "drugbank_resource:DB00701_DB00909" assertion.
- drugbank_resource:DB00701_DB00909 title "DDI between Amprenavir and Zonisamide - Amprenavir, a strong CYP3A4 inhibitor, may increase the serum concentration of zonisamide by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zonisamide if amprenavir is initiated, discontinued or dose changed." assertion.
- drugbank:DB00909 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00701_DB00909 assertion.
- drugbank:DB00701 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00701_DB00909 assertion.